Literature DB >> 4040429

Evaluation of cisplatin in children with recurrent brain tumors.

B Diez, J Monges, F S Muriel.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1985        PMID： 4040429

Source DB:  PubMed          Journal:  Cancer Treat Rep        ISSN： 0361-5960


× No keyword cloud information.
  9 in total

Review 1.  Clinical management of brain stem glioma.

Authors:  D A Walker; J A Punt; M Sokal
Journal:  Arch Dis Child       Date:  1999-06       Impact factor: 3.791

Review 2.  Strategies in the treatment of diffuse pontine gliomas: the therapeutic role of hyperfractionated radiotherapy and chemotherapy.

Authors:  M T Jennings; M L Freeman; M J Murray
Journal:  J Neurooncol       Date:  1996 May-Jun       Impact factor: 4.130

3.  Selective cytoplasmic and membrane changes induced by cisplatinum.

Authors:  M A Oberc-Greenwood; B H Smith; C Cooke; C Pepin; P L Kornblith
Journal:  J Neurooncol       Date:  1990-12       Impact factor: 4.130

Review 4.  Pharmacotherapy of malignant astrocytomas of children and adults: current strategies and future trends.

Authors:  M T Jennings; S Iyengar
Journal:  CNS Drugs       Date:  2001       Impact factor: 5.749

5.  Pre-irradiation chemotherapy in children with high-grade astrocytoma: tumor response to two cycles of the '8-drugs-in-1-day' regimen. A Childrens Cancer Group study, CCG-945.

Authors:  J L Finlay; J R Geyer; P A Turski; A J Yates; J M Boyett; J C Allen; R J Packer
Journal:  J Neurooncol       Date:  1994       Impact factor: 4.130

6.  Direct delivery of platinum-based antineoplastics to the central nervous system: a toxicity and ultrastructural study.

Authors:  A Olivi; M Gilbert; K L Duncan; B Corden; D Lenartz; H Brem
Journal:  Cancer Chemother Pharmacol       Date:  1993       Impact factor: 3.333

7.  Platinum-based chemotherapy for recurrent CNS tumours in young patients.

Authors:  E Douek; J E Kingston; J S Malpas; P N Plowman
Journal:  J Neurol Neurosurg Psychiatry       Date:  1991-08       Impact factor: 10.154

8.  Cisplatin, ara-C and etoposide (PAE) in the treatment of recurrent childhood brain tumors.

Authors:  B J Corden; L C Strauss; T Killmond; B S Carson; M D Wharam; A J Kumar; S Piantadosi; P A Robb; P C Phillips
Journal:  J Neurooncol       Date:  1991-08       Impact factor: 4.130

9.  A phase II study of cisplatin therapy in recurrent childhood brain tumors. A report from the Childrens Cancer Study Group.

Authors:  S J Bertolone; E S Baum; W Krivit; G D Hammond
Journal:  J Neurooncol       Date:  1989-05       Impact factor: 4.130
  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.